U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935564) titled 'A Study to Assess the Adverse Events and How Oral ABBV-1606 Moves Through the Body of Healthy Adult Participants.' on Sept. 18, 2025.
Brief Summary: This study will assess the adverse events, tolerability, and how oral ascending doses of ABBV-1606 moves through the body of healthy adult participants.
Study Start Date: Nov. 10
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ABBV-1606
Oral Solution
DRUG: Placebo
Oral Solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....